MRNA

195.0002.17%
SH

Stephen Hoge

President

Dr. Stephen Hoge, M.D., serves as President of Moderna, Inc. (formerly known as Moderna Therapeutics, Inc.) since February 2015. He serves as President at Valera LLC. Dr. Hoge served as Senior Vice President of Corporate Development and New Drug Concepts at Moderna, Inc. (formerly known as Moderna Therapeutics, Inc.) since January 1, 2013. Prior to Moderna, Dr. Hoge was a Partner of McKinsey & Company and a leader in its global Healthcare and Corporate Finance practices. At McKinsey, he advised senior management teams of leading biotech and pharmaceutical companies on a wide range of strategic, financial and operational issues. He also led McKinsey's thinking on R&D portfolio development and valuation. He has leading strategy, corporate development and medical experience. He served as Director of Axcella Health, Inc. since May 2014 until May 05, 2022. He was a Physician in New York. Dr. Hoge holds an MD with thesis from the University of California, San Francisco and a BA in Neuroscience from Amherst College.

Positions